Loading...

Seth Bechis

Title(s)Assistant Clinical Professor, Urology
SchoolVc-health Sciences-schools
Address200 W. Arbor Drive #8897
San Diego CA 92103
Phone8/5-43--2869
ORCID ORCID Icon0000-0002-2430-2893 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Massachusetts General Hospital, Boston, MAResidencyUrology Residency
    UC San Diego, San Diego, CAFellowshipFellowship in Endourology and Robotic Surgery
    University of California, San Francisco, San Francisco, CAM.S.Biomedical Sciences
    University of California, San Francisco, San Francisco, CAM.D.Medicine
    Harvard University, Cambridge, MAA.B.Chemistry
    Collapse Awards and Honors
    AUA National Meeting 2015 Boston, MA2015  - 2015Best Abstract, Plenary Session
    UC San Diego2017  - 2017UCSD Academy of Clinician Scholars Kaiser Research Award for Faculty Development
    UCSD Academy of Clinician Scholars 2019  - 2019Whitehill Award for Excellence in Clinical Teaching

    Collapse Overview 
    Collapse Overview
    Seth Bechis, MD, is a board-certified urologist who cares for patients with diseases of the urinary tract, including kidney stones, benign prostatic hyperplasia (BPH) or enlarged prostate, and men’s health issues. As member of the comprehensive Kidney Stone Center at UC San Diego Health, he has a special interest in advanced surgical treatment, medical prevention and research on kidney stone disease. He also performs advanced procedures for BPH as well as robotic surgery.

    As an urologist at an academic medical center, Dr. Bechis is involved in teaching and education. He also serves as the assistant program director for the UC San Diego - Kaiser Laparoscopy/Endourology Fellowship in the Department of Urology at UC San Diego School of Medicine.

    His previous research includes the study of molecular pathways in the progression of benign prostatic hyperplasia, risk factors for stone formation, and analysis of age and other risk factors on predicting prostate cancer-specific survival. His research has been featured in peer-reviewed medical journals, including Urologic Oncology, Journal of Urology, and American Journal of Pathology. Additionally, he was editor of First Aid Q&A for the USMLE Step 1, Second Edition and has authored chapters for university handbooks.

    Prior to joining UC San Diego Health, Dr. Bechis worked at Massachusetts General Hospital and Harvard Medical School, where he taught residents and medical students in the operating room and clinic.

    Dr. Bechis has won numerous awards and honors over the years, including the Plenary Address for Best Abstract from the American Urological Association in 2015, and first place in the 2014 Max K. Willscher Resident Research Award Competition. He has been invited to speak nationally at conferences on topics including benign prostatic hyperplasia and nephrolithiasis.

    Dr. Bechis completed fellowship training in laparoscopy/robotics and endourology at UC San Diego School of Medicine, and residency training at Harvard Medical School, Massachusetts General Hospital. He earned his medical degree from the University of California, San Francisco School of Medicine and holds additional Master of Science training in biomedical research, also from UCSF. Biomedical research (or experimental medicine) focuses on ways to prevent and treat diseases. It is a key component of the Kidney Stone Center, which offers patients access to clinical trials that examine newly developed therapies and procedures.

    Dr. Bechis is a member of several professional medical organizations, including the American Urological Association, the Endourology Society, and the American Association of Clinical Urologists. He is Board Certified by the American Board of Urology.

    Collapse Research 
    Collapse Research Activities and Funding
    Endourology Kidney Stone Research

    Collapse ORNG Applications 
    Collapse Featured Publications
    Collapse Websites
    Collapse In The News

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Androgenic to oestrogenic switch in the human adult prostate gland is regulated by epigenetic silencing of steroid 5a-reductase 2. J Pathol. 2017 12; 243(4):457-467. Wang Z, Hu L, Salari K, Bechis SK, Ge R, Wu S, Rassoulian C, Pham J, Wu CL, Tabatabaei S, Strand DW, Olumi AF. PMID: 28940538.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    2. Voiding Dysfunction in Multiple Sclerosis. Semin Neurol. 2016 04; 36(2):219-20. Wintner A, Kim MM, Bechis SK, Kreydin EI. PMID: 27116728.
      View in: PubMed   Mentions: 1     Fields:    
    3. Voiding Dysfunction in Multiple Sclerosis. Semin Neurol. 2016 Feb; 36(1):34-40. Wintner A, Kim MM, Bechis SK, Kreydin EI. PMID: 26866494.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    4. Primary genitourinary melanoma: Epidemiology and disease-specific survival in a large population-based cohort. Urol Oncol. 2016 Apr; 34(4):166.e7-14. Sanchez A, Rodríguez D, Allard CB, Bechis SK, Sullivan RJ, Boeke CE, Kuppermann D, Cheng JS, Barrisford GW, Preston MA, Feldman AS. PMID: 26739672.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    5. Age and Obesity Promote Methylation and Suppression of 5a-Reductase 2: Implications for Personalized Therapy of Benign Prostatic Hyperplasia. J Urol. 2015 Oct; 194(4):1031-7. Bechis SK, Otsetov AG, Ge R, Wang Z, Vangel MG, Wu CL, Tabatabaei S, Olumi AF. PMID: 25916673.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    6. DNA methyl transferase 1 reduces expression of SRD5A2 in the aging adult prostate. Am J Pathol. 2015 Mar; 185(3):870-82. Ge R, Wang Z, Bechis SK, Otsetov AG, Hua S, Wu S, Wu CL, Tabatabaei S, Olumi AF. PMID: 25700986.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    7. Editorial comment. Urology. 2014 Sep; 84(3):542-3. Bechis SK, Eisner BH. PMID: 25168530.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. The STONE score can help diagnose urolithiasis and decrease the use of CT scans. Evid Based Med. 2014 Dec; 19(6):234. Bechis SK, Eisner BH. PMID: 25053641.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. Personalized medicine for the management of benign prostatic hyperplasia. J Urol. 2014 Jul; 192(1):16-23. Bechis SK, Otsetov AG, Ge R, Olumi AF. PMID: 24582540.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    10. Impact of age at diagnosis on prostate cancer treatment and survival. J Clin Oncol. 2011 Jan 10; 29(2):235-41. Bechis SK, Carroll PR, Cooperberg MR. PMID: 21135285.
      View in: PubMed   Mentions: 74     Fields:    Translation:Humans
    11. Diabetic kidney stone formers excrete more oxalate and have lower urine pH than nondiabetic stone formers. J Urol. 2010 Jun; 183(6):2244-8. Eisner BH, Porten SP, Bechis SK, Stoller ML. PMID: 20400141.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    12. The role of race in determining 24-hour urine composition in white and Asian/Pacific Islander stone formers. J Urol. 2010 Apr; 183(4):1407-11. Eisner BH, Porten SP, Bechis SK, Stoller ML. PMID: 20171692.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    13. Hypertension is associated with increased urinary calcium excretion in patients with nephrolithiasis. J Urol. 2010 Feb; 183(2):576-9. Eisner BH, Porten SP, Bechis SK, Stoller ML. PMID: 20018328.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    Seth's Networks
    Concepts (71)
    Derived automatically from this person's publications.
    _
    Co-Authors (5)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _